QL
CRNX

Quarry LP’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quarry LP’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655K Buy
+17,500
New +$651K 0.05% 121
2026
Q1 		– Sell
-30
Closed -$1.4K – 1601
2025
Q4 		$1.4K Buy
+30
New +$1.34K ﹤0.01% 1947
2024
Q1 		– Sell
-1,000
Closed -$35.6K – 1684
2023
Q4 		$35.6K Buy
+1,000
New +$30.7K 0.01% 459

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quarry LP's CRNX Position: Q2 2026 in Review

Quarry LP opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 17,500 shares worth $655K. The stake represents 0.05% of the portfolio and ranks #121 among its holdings. This is a return to the name: Quarry LP previously reported a position in CRNX as recently as Q4 2025.

Quarry LP first reported a position in CRNX in Q4 2023 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Quarry LP held 17,500 shares of Crinetics Pharmaceuticals worth $655K as of Q2 2026.
  • Crinetics Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • Crinetics Pharmaceuticals made up 0.05% of Quarry LP's portfolio in Q2 2026, its #121 holding.
  • Quarry LP first reported a position in Crinetics Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.